Jin Shuiling, Weng Lanling, Li Zhi, Yang Zhenzhen, Zhu Lili, Shi Jianxiang, Tang Wenxue, Ma Wang, Zong Hong, Jiang Wei
Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
J Mater Chem B. 2020 Jun 7;8(21):4620-4626. doi: 10.1039/d0tb00357c. Epub 2020 May 6.
Chemodynamic therapy (CDT) has been critically challenged by insufficient HO in cancer tissues and inefficient reactive oxygen species (ROS) production. Herein, we have reported the facile synthesis of an efficient ROS generator (GOx@Pd@ZIF-8) that exerts synergistic anticancer activity by blocking glucose metabolism and producing ROS. Glucose oxidase (GOx) and palladium (Pd) cube nanozymes were incorporated in zeolitic imidazolate framework-8 (ZIF-8) by biomimetic mineralization. Systematic characterization indicated the successful entrapment and embedding of GOx and Pd during ZIF-8 crystal growth. The GOx@Pd@ZIF-8 composite showed favorable catalytic glucose activity and stable ROS production. In vitro experiments showed that the GOx@Pd@ZIF-8 composite effectively inhibited cancer cell proliferation, invasion, and migration and promoted apoptosis through the ROS-mediated signaling pathway, which was further confirmed by bioinformatics analyses of RNA-seq data obtained from in vitro experiments. Furthermore, the GOx@Pd@ZIF-8 composite inhibited tumor growth with few to no side effects on other tissues in vivo. This work provides a novel antitumor strategy involving the construction of a stable and highly active ROS generator that shows promise for the treatment of solid cancers.
Angew Chem Int Ed Engl. 2017-11-20
J Mater Chem B. 2021-7-28
ACS Appl Mater Interfaces. 2022-2-2
Colloids Surf B Biointerfaces. 2024-8
Redox Biol. 2025-7-18
Adv Healthc Mater. 2023-10
Biomater Sci. 2022-11-22
Front Bioeng Biotechnol. 2022-5-30
Nano Converg. 2022-2-4